Anti-TREML2 antibodies are used in the immunodetection of the protein triggering receptor expressed on myeloid cells like 2. In humans, the canonical protein has a reported length of 321 amino acid residues and a mass of 35.1 kDa. Its subcellular localization is in the cell membrane. It is notably expressed in cultured B-cells, T-cell leukemia and monocyte leukemia. TREML2 is a reported cell surface receptor that may play a role in the innate and adaptive immune response. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include trem-like transcript 2 protein and triggering receptor expressed on myeloid cells-like protein 2. TREML2 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. A number of TREML2 antibodies have been mentioned in research publications and have associated citations. ELISA is a widely used application for these antibodies. Flow Cytometry and Western Blot are also common applications.